Works matching Myelosuppression
Results: 3243
Prospective Observational Study on the Risk Factors of Chemotherapy-Induced Myelosuppression and Its Management in a Tertiary Care Hospital.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2024, v. 45, n. 5, p. 416, doi. 10.1055/s-0043-1770905
- By:
- Publication type:
- Article
Myeloprotective potential of Malus domestica (Apple) in Carboplatin induced myelosuppression in Swiss albino rats-A way to prevent Dengue and similar viral diseases.
- Published in:
- Annals of King Edward Medical University, 2018, v. 24, n. 4, p. 1
- By:
- Publication type:
- Article
Transcriptome Profiling Analysis Reveals the Potential Mechanisms of Three Bioactive Ingredients of Fufang E'jiao Jiang During Chemotherapy-Induced Myelosuppression in Mice.
- Published in:
- Frontiers in Pharmacology, 2018, p. 1, doi. 10.3389/fphar.2018.00616
- By:
- Publication type:
- Article
A randomized trial of Bacteroides fragilis 839 on preventing chemotherapy-induced myelosuppression and gastrointestinal adverse effects in breast cancer patients.
- Published in:
- Asia Pacific Journal of Clinical Nutrition, 2024, v. 33, n. 1, p. 23, doi. 10.6133/apjcn.202403_33(1).0003
- By:
- Publication type:
- Article
Cancer Patients' Perspectives and Experiences of Chemotherapy-Induced Myelosuppression and Its Impact on Daily Life.
- Published in:
- Patient Preference & Adherence, 2021, v. 15, p. 453, doi. 10.2147/PPA.S292462
- By:
- Publication type:
- Article
Nucleosides and amino acids, isolated from Cordyceps sinensis, protected against cyclophosphamide-induced myelosuppression in mice.
- Published in:
- Natural Product Research, 2022, v. 36, n. 23, p. 6056, doi. 10.1080/14786419.2022.2043307
- By:
- Publication type:
- Article
Burden of chemotherapy‐induced myelosuppression among patients with extensive‐stage small cell lung cancer: A retrospective study from community oncology practices.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 8, p. 10020, doi. 10.1002/cam4.5738
- By:
- Publication type:
- Article
Exosomal miR-122-5p is Related to the Degree of Myelosuppression Caused by Chemotherapy in Patients with Colorectal Cancer.
- Published in:
- Cancer Management & Research, 2021, v. 13, p. 8329, doi. 10.2147/CMAR.S332384
- By:
- Publication type:
- Article
Factors Predicting Severe Myelosuppression and Its Influence on Fertility in Patients with Low-Risk Gestational Trophoblastic Neoplasia Receiving Single-Agent Methotrexate Chemotherapy.
- Published in:
- Cancer Management & Research, 2020, v. 12, p. 4107, doi. 10.2147/CMAR.S252664
- By:
- Publication type:
- Article
Association between chemotherapy-induced myelosuppression and curative efficacy of 2-cycle chemotherapy in small cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2024, v. 93, n. 2, p. 151, doi. 10.1007/s00280-023-04608-6
- By:
- Publication type:
- Article
Quantitative evaluation of myelosuppression after chemotherapy for patients with ovarian cancer using material decomposition in dual-energy computed tomography.
- Published in:
- European Journal of Gynaecological Oncology, 2023, v. 44, n. 1, p. 79, doi. 10.22514/ejgo.2023.009
- By:
- Publication type:
- Article
Hematopoietic Effects of Angelica gigas Nakai Extract on Cyclophosphamide-Induced Myelosuppression.
- Published in:
- Plants (2223-7747), 2022, v. 11, n. 24, p. 3476, doi. 10.3390/plants11243476
- By:
- Publication type:
- Article
Reassembling of albumin-bound paclitaxel mitigates myelosuppression and improves its antitumoral efficacy via neutrophil-mediated targeting drug delivery.
- Published in:
- Drug Delivery, 2022, v. 29, n. 1, p. 728, doi. 10.1080/10717544.2022.2046892
- By:
- Publication type:
- Article
Improvement of icaritin on hematopoietic function in cyclophosphamide-induced myelosuppression mice.
- Published in:
- Immunopharmacology & Immunotoxicology, 2018, v. 40, n. 1, p. 25, doi. 10.1080/08923973.2017.1392564
- By:
- Publication type:
- Article
Jian-Pi-Bu-Xue-Formula Alleviates Cyclophosphamide-Induced Myelosuppression via Up-Regulating NRF2/HO1/NQO1 Signaling.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. N.PAG, doi. 10.3389/fphar.2020.01302
- By:
- Publication type:
- Article
Ginsenoside Rg3 for Chemotherapy-Induced Myelosuppression: A Meta-Analysis and Systematic Review.
- Published in:
- Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00649
- By:
- Publication type:
- Article
Asperuloside alleviates cyclophosphamide‐induced myelosuppression by promoting AMPK/mTOR pathway‐mediated autophagy.
- Published in:
- Journal of Biochemical & Molecular Toxicology, 2024, v. 38, n. 2, p. 1, doi. 10.1002/jbt.23641
- By:
- Publication type:
- Article
The efficacy and safety of Trilaciclib in preventing chemotherapy-induced myelosuppression: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1157251
- By:
- Publication type:
- Article
Case report: NUDT15 polymorphism and severe azathioprine-induced myelosuppression in a young Chinese female with systematic lupus erythematosus: a case analysis and literature review.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1001559
- By:
- Publication type:
- Article
Effects of Yifukang Oral Liquid on Chemotherapy- and Radiotherapy-Induced Toxic and Side Effects of Myelosuppression, Leucopenia and Gastrointestinal Tract Disturbances.
- Published in:
- Tropical Journal of Pharmaceutical Research, 2015, v. 14, n. 11, p. 2023, doi. 10.4314/tjpr.v14i11.11
- By:
- Publication type:
- Article
Model-based prediction of myelosuppression and recovery based on frequent neutrophil monitoring.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Relation of age with myelosuppression induced by the CHOP regimen in patients with Non-Hodgkin’s Lymphoma.
- Published in:
- Cancer Therapy, 2009, v. 7, p. 133
- By:
- Publication type:
- Article
Imatinib-induced severe hematological toxicity: Prolonged myelosuppression resulting from extraordinary sensitivity in an old age.
- Published in:
- European Journal of Inflammation, 2023, p. 1, doi. 10.1177/1721727X231158468
- By:
- Publication type:
- Article
Imatinib-induced severe hematological toxicity: Prolonged myelosuppression resulting from extraordinary sensitivity in an old age.
- Published in:
- European Journal of Inflammation, 2023, v. 21, p. 1, doi. 10.1177/1721727X231158468
- By:
- Publication type:
- Article
HER2 exon 20 insertion mutations and myelosuppression in lung adenocarcinoma patient: a case report and response to trastuzumab deruxtecan.
- Published in:
- Journal of Cardiothoracic Surgery, 2023, v. 18, n. 1, p. 1, doi. 10.1186/s13019-023-02181-w
- By:
- Publication type:
- Article
Astragaloside IV and Saponins of Rhizoma Polygonati Cure Cyclophosphamide-Induced Myelosuppression in Lung Adenocarcinoma via Down-Regulating miR-142-3p.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.630921
- By:
- Publication type:
- Article
Low‐Intensity Pulsed Ultrasound Relieves Mild and Severe Myelosuppression Induced by Cyclophosphamide in Rabbits.
- Published in:
- Journal of Ultrasound in Medicine, 2019, v. 38, n. 10, p. 2721, doi. 10.1002/jum.14979
- By:
- Publication type:
- Article
Transient chemotherapy‐induced alopecia after successful reversal of 5‐fluorouracil myelosuppression and neurotoxicosis in a 9‐month‐old dog.
- Published in:
- Australian Veterinary Journal, 2022, v. 100, n. 6, p. 236, doi. 10.1111/avj.13154
- By:
- Publication type:
- Article
Adverse Events in Osimertinib Treatment for EGFR-Mutated Non-Small-Cell Lung Cancer: Unveiling Rare Life-Threatening Myelosuppression.
- Published in:
- Medicina (1010660X), 2024, v. 60, n. 8, p. 1270, doi. 10.3390/medicina60081270
- By:
- Publication type:
- Article
Prevention Effect of Protopanaxadiol-Type Saponins Saponins and Protopanaxatriol-Type Saponins on Myelosuppression Mice Induced by Cyclophosphamide.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.845034
- By:
- Publication type:
- Article
Ayurveda-based Botanicals as Therapeutic Adjuvants in Paclitaxel-induced Myelosuppression.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.835616
- By:
- Publication type:
- Article
Association Between Genetic Polymorphisms of Metabolic Enzymes and Azathioprine-Induced Myelosuppression in 1,419 Chinese Patients: A Retrospective Study.
- Published in:
- Frontiers in Pharmacology, 2021, v. 11, p. N.PAG, doi. 10.3389/fphar.2021.672769
- By:
- Publication type:
- Article
A herbal formula, SYKT, reverses doxorubicin-induced myelosuppression and cardiotoxicity by inhibiting ROS-mediated apoptosis.
- Published in:
- Molecular Medicine Reports, 2017, v. 15, n. 4, p. 2057, doi. 10.3892/mmr.2017.6272
- By:
- Publication type:
- Article
Protective effect of 20(R)-ginsenoside Rg3 on chemotherapy-induced myelosuppression in mice.
- Published in:
- Pharmacognosy Magazine, 2022, v. 18, n. 79, p. 685, doi. 10.4103/pm.pm_451_21
- By:
- Publication type:
- Article
Hemostimulating Effects of c-Jun N-Terminal Kinase (JNK) Inhibitor during Cytostatic Myelosuppression and Mechanisms of Their Development.
- Published in:
- Bulletin of Experimental Biology & Medicine, 2020, v. 169, n. 3, p. 332, doi. 10.1007/s10517-020-04880-z
- By:
- Publication type:
- Article
The association of four genetic variants with myelosuppression in gemcitabine‐treated Japanese is not evident in gemcitabine/carboplatin‐treated Swedes.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2022, v. 130, n. 4, p. 513, doi. 10.1111/bcpt.13712
- By:
- Publication type:
- Article
Nitrogen mustard hydrochloride-induced acute respiratory failure and myelosuppression: A case report.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
Trilaciclib: A Novel Approach to Mitigate Chemotherapy-Induced Myelosuppression in Cancer Treatment.
- Published in:
- Indian Journal of Medical & Paediatric Oncology, 2024, v. 45, n. 4, p. 320, doi. 10.1055/s-0044-1786017
- By:
- Publication type:
- Article
Splenunculus mimicking splenomegaly in a patient with synchronous herpes simplex 1 viremia and myelosuppression.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
H<sub>2</sub>S protects against fatal myelosuppression by promoting the generation of megakaryocytes/platelets.
- Published in:
- Journal of Hematology & Oncology, 2016, v. 9, p. 1, doi. 10.1186/s13045-016-0244-7
- By:
- Publication type:
- Article
Structural identifiability for mathematical pharmacology: models of myelosuppression.
- Published in:
- Journal of Pharmacokinetics & Pharmacodynamics, 2018, v. 45, n. 1, p. 79, doi. 10.1007/s10928-018-9569-x
- By:
- Publication type:
- Article
STS1 and STS2 Phosphatase Inhibitor Baicalein Enhances the Expansion of Hematopoietic and Progenitor Stem Cells and Alleviates 5-Fluorouracil-Induced Myelosuppression.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 3, p. 2987, doi. 10.3390/ijms24032987
- By:
- Publication type:
- Article
Myelosuppression by chemotherapy in obese patients with gynecological cancers.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Lurasidone Induced Thrombocytopenia: Is it a Signal of Drug Induced Myelosuppression?
- Published in:
- Indian Journal of Psychological Medicine, 2018, v. 40, n. 2, p. 191, doi. 10.4103/IJPSYM.IJPSYM_374_17
- By:
- Publication type:
- Article
A Case Report Of Linezolid (Lzd) Induced Complete Myelosuppression.
- Published in:
- 2017
- By:
- Publication type:
- Case Study
Prevalence of hepatotoxicity and myelosuppression with alternate day use of azathioprine and glucocorticoids for treatment of dermatological conditions in dogs.
- Published in:
- Veterinary Dermatology, 2022, v. 33, n. 6, p. 503, doi. 10.1111/vde.13115
- By:
- Publication type:
- Article
2646. Incidence of Myelosuppression Related to Valganciclovir Prophylaxis in Solid-Organ Transplant Recipients at High Risk of CMV Disease.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, p. S925, doi. 10.1093/ofid/ofz360.2324
- By:
- Publication type:
- Article
A Pharmacometric Model to Predict Chemotherapy-Induced Myelosuppression and Associated Risk Factors in Non-Small Cell Lung Cancer.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 5, p. 914, doi. 10.3390/pharmaceutics14050914
- By:
- Publication type:
- Article
38 Cases of Myelosuppression Induced by Cancer Chemotherapy Treated with Acupuncture.
- Published in:
- International Journal of Clinical Acupuncture, 2015, v. 24, n. 3, p. 175, doi. 10.3103/S1047197915030126
- By:
- Publication type:
- Article
Translational Modeling of Drug-Induced Myelosuppression and Effect of Pretreatment Myelosuppression for AZD5153, a Selective BRD4 Inhibitor.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2017, v. 6, n. 6, p. 357, doi. 10.1002/psp4.12194
- By:
- Publication type:
- Article